This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Ferez M , Knudson CJ , Lev A , Wong EB , Alves-Peixoto P , Tang L , Stotesbury C , Sigal LJ
Viral infection modulates Qa-1b in infected and bystander cells to properly direct NK cell killing
J Exp Med. 2021 May 3;218(5)
PMID: 33765134 PMCID: PMC8006856 URL: https://www.ncbi.nlm.nih.gov/pubmed/33765134
AbstractNatural killer (NK) cell activation depends on the signaling balance of activating and inhibitory receptors. CD94 forms inhibitory receptors with NKG2A and activating receptors with NKG2E or NKG2C. We previously demonstrated that CD94-NKG2 on NK cells and its ligand Qa-1b are important for the resistance of C57BL/6 mice to lethal ectromelia virus (ECTV) infection. We now show that NKG2C or NKG2E deficiency does not increase susceptibility to lethal ECTV infection, but overexpression of Qa-1b in infected cells does. We also demonstrate that Qa-1b is down-regulated in infected and up-regulated in bystander inflammatory monocytes and B cells. Moreover, NK cells activated by ECTV infection kill Qa-1b-deficient cells in vitro and in vivo. Thus, during viral infection, recognition of Qa-1b by activating CD94/NKG2 receptors is not critical. Instead, the levels of Qa-1b expression are down-regulated in infected cells but increased in some bystander immune cells to respectively promote or inhibit their killing by activated NK cells.
Notes1540-9538 Ferez, Maria Knudson, Cory J Lev, Avital Wong, Eric B Alves-Peixoto, Pedro Tang, Lingjuan Stotesbury, Colby Sigal, Luis J R01 AI110457/AI/NIAID NIH HHS/United States T32 AI134646/AI/NIAID NIH HHS/United States R01 AG048602/AG/NIA NIH HHS/United States R01 AI065544/AI/NIAID NIH HHS/United States F32 AI129352/AI/NIAID NIH HHS/United States Journal Article United States J Exp Med. 2021 May 3;218(5):e20201782. doi: 10.1084/jem.20201782.